Bacteria are single-celled organisms that are extremely small. Although the majority of bacteria are harmless, some can infect people and cause diseases. A few have even been linked to the development of cancer. Apart from inducing cancer by interfering with the host's normal defense mechanisms such as inflammation and antigen recognition, some bacteria have been found to produce tumor proteins as a result of metabolic products, which have direct myogenic or mutagenic effects.
Despite the fact that traditional cancer treatments remain the most prominent, bacterial therapy has demonstrated significant results due to its high specificity, ability to control after ingestion, and presence in several live experiments. Because of its tumor selectivity and large gene packaging capability, bacteria targeting tumors is an ideal strategy to administer therapeutic treatments.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : A case-based approach using IMPeTUs criteria in FDG PET/CT reporting of multiple myeloma
Mudalsha Ravina, All India Institute of Medical Sciences, India
Title : Transforming cancer care: Innovations, integrations, and impact
Shayan Maqsood, Jamia Hamdard University, India
Title : Updates on controversies surrounding the staging and management of newly diagnosed localized prostate cancer using prostate-specific membrane antigen (PSMA) positron emission tomography
Patricia Tai, University of Saskatchewan, Canada
Title : Advanced nanoparticles, the hallmark of targeted drug delivery for osteosarcoma
Shayan Maqsood, Jamia Hamdard University, India